From endothelial dysfunction to atherosclerosis

Autoimmunity Reviews

Volumn 9, Issue 12, 2010, Pages 830-834

  Sitia, S ^a   Tomasoni, L ^a   Atzeni, F ^b   Ambrosio, G ^c   Cordiano, C ^c   Catapano, A ^a   Tramontana, S ^a   Perticone, F ^d   Naccarato, P ^d   Camici, P ^e   Picano, E ^f   Cortigiani, L ^f   Bevilacqua, M ^b   Milazzo, L ^b   Cusi, D ^a   Barlassina, C ^a   Sarzi Puttini, P ^b   Turiel, M ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c UNIVERSITY OF PERUGIA   (Italy)

^d UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^e NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^f INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

Author keywords

Arterial hypertension; Atherosclerosis; Autoimmune diseases; Coronary microcirculation; Endothelial dysfunction; Inflammation

Indexed keywords

CYTOKINE; NITRIC OXIDE;

ATHEROSCLEROSIS; AUTOIMMUNE DISEASE; AUTOIMMUNITY; BIOAVAILABILITY; BRACHIAL ARTERY; CARDIOVASCULAR RISK; CORONARY ARTERY DISEASE; CORONARY FLOW RESERVE; DIABETES MELLITUS; DYSLIPIDEMIA; ENDOTHELIAL DYSFUNCTION; GENETIC POLYMORPHISM; HUMAN; HYPERTENSION; IMMUNE SYSTEM; IMMUNOPATHOGENESIS; INSULIN RESISTANCE; METABOLIC SYNDROME X; PATHOPHYSIOLOGY; REVIEW; RISK FACTOR; SYSTEMIC DISEASE; TRANSTHORACIC ECHOCARDIOGRAPHY; VASCULAR ENDOTHELIUM; VASODILATATION;

ANIMALS; ATHEROSCLEROSIS; AUTOIMMUNITY; CALMODULIN-BINDING PROTEINS; CORONARY VESSELS; ECHOCARDIOGRAPHY; ENDOTHELIUM, VASCULAR; GENETIC PREDISPOSITION TO DISEASE; HUMANS; HYPERTENSION; LASER-DOPPLER FLOWMETRY; POLYMORPHISM, GENETIC; RENIN-ANGIOTENSIN SYSTEM; RISK;

EID: 77956934512     PISSN: 15689972     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.autrev.2010.07.016     Document Type: Review

References (37)

1. Tritto I., Ambrosio G. The multi-faceted behavior of nitric oxide in vascular "inflammation": catchy terminology or true phenomenon?. Cardiovasc Res 2004, 63:1-4.
2. Zardi E.M., Afeltra A. Endothelial dysfunction and vascular stiffness in systemic lupus erythematosus: are they early markers of subclinical atherosclerosis?. Autoimmun Rev 2010 Aug, 9(10):684-686. [Electronic publication ahead of print 2010 May 26].
3. Stojanovich L. Autonomic dysfunction in autoimmune rheumatic disease. Autoimmun Rev 2009, 8:569-572.
4. Zinger H., Sherer Y., Shoenfeld Y. Atherosclerosis in autoimmune rheumatic diseases - mechanisms and clinical findings. Clin Rev Allerg Immunol 2009, 37:20-28.
5. Montecucco F., Mach F. Common inflammatory mediators orchestrate pathophysiological processes in rheumatoid arthritis and atherosclerosis. Rheumatology 2009, 48:11-22.
6. Hansson G.K., Libby P. The immune response in atherosclerosis: a double-edged sword. Nat Rev Immunol 2006, 6:508-519.
7. Hahn B.H., Grossman J., Chen W., McMahon M. The pathogenesis of atherosclerosis in autoimmune rheumatic diseases: roles of inflammation and dyslipidemia. J Autoimmun 2007, 28:69-75.
8. Peters M.J., van Halm V.P., Nurmohamed M.T., Damoiseaux J., Tervaert J.W., Twisk J.W., et al. Relations between autoantibodies against oxidized low-density lipoprotein, inflammation, subclinical atherosclerosis, and cardiovascular disease in rheumatoid arthritis. J Rheumatol 2008, 35:1495-1499.
9. Matsuura E., Kobayashi K., Matsunami Y., Shen L., Quan N., Makarova M., et al. Autoimmunity, infectious immunity, and atherosclerosis. J Clin Immunol 2009, 29:714-721.
10. Ames B.N. Low micronutrient intake may accelerate the degenerative diseases of aging through allocation of scarce micronutrients by triage. Proc Natl Acad Sci USA 2006, 103:17589-17594.
11. Waterland R.A., Michels K.B. Epigenetic epidemiology of the developmental origins hypothesis. Ann Rev Nutr 2007, 27:363-388.
12. Glorioso N., Filigheddu F., Cusi D., Troffa C., Conti M., et al. Alpha-Adducin 460Trp allele is associated with erythrocyte Na transport rate in North Sardinian primary hypertensives. Hypertension 2002, 39:357-362.
13. Sciarrone M.T., Stella P., Barlassina C., Manunta P., Lanzani C., Bianchi G., et al. ACE and alpha-adducin polymorphism as markers of individual response to diuretic therapy. Hypertension 2003, 41:398-403.
14. Barlassina C., Schork N.J., Manunta P., Citterio L., Sciarrone M., Lanella G., et al. Synergistic effect of alpha-adducin and ACE genes causes blood pressure changes with body sodium and volume expansion. Kidney Int 2000, 57:1083-1090.
15. Morrison A.C., Bray M.S., Folsom A.R., Boerwinkle E. ADD1 460W allele associated with cardiovascular disease in hypertensive individuals. Hypertension 2002, 39:1053-1057.
16. Zafarmand M.H., Van der Schouw Y.T., Grobbee D.E., de Leeuw P.W., Bots M.L. Alpha-Adducin Gly460Trp variant increases the risk of stroke in hypertensive Dutch women. Hypertension 2008, 51:1665-1670.
17. Norata G.D., Tonti L., Roma P., Catapano A.L. Apoptosis and proliferation of endothelial cells in early atherosclerotic lesions: possible role of oxidized LDL. Nutr Metab Cardiovasc Dis 2002, 12:297-305.
18. Norata G.D., Callegari E., Inoue H., Catapano A.L. HDL3 induces cyclooxygenase-2 expression and prostacyclin release in human endothelial cells via a p38 MAPK/CRE-dependent pathway: effects on COX2/PGI synthase coupling. Arterioscler Thromb Vasc Biol 2004, 24:871-877.
19. Norata G.D., Catapano A.L. Molecular mechanisms responsible for the antiinflammatory and protective effect of HDL on the endothelium. Vasc Health Risk Manag 2005, 1:119-129.
20. Matsuura E., Hughes G.R., Khamashta M.A. Oxidation of LDL and its clinical implication. Autoimmun Rev 2008, 7:558-566.
21. Daugherty A., Rateri D.L., Lu H., Inagami T., Cassis L.A. Hypercholesterolemia stimulates angiotensin peptide synthesis and contributes to atherosclerosis through the AT1A receptor. Circulation 2004, 110:3849-3857.
22. Wassmann S., Hilgers S., Laufs U., Böhm M., Nickenig G. Angiotensin II Type 1 receptor antagonism improves hypercholesterolemia-associated endothelial dysfunction. Arterioscler Thromb Vasc Biol 2002, 22:1208-1212.
23. Vladimirova-Kitova L., Deneva T., Angelova E., Nikolov F., Marinov B., Mateva N. Relationship of asymmetric dimethylarginine with flow-mediated dilatation in subjects with newly detected severe hypercholesterolemia. Clin Physiol Funct Imaging 2008, 28:417-425.
24. Perticone F., Sciacqua A., Maio R., Perticone M., Maas R., Boger R.H., et al. Asymmetric dimethylarginine, l-arginine, and endothelial dysfunction in essential hypertension. J Am Coll Cardiol 2005, 46:518-523.
25. De Gennaro Colonna V., Bianchi M., Pascale V., Ferrario P., Morelli F., Pascale W., et al. Asymmetric dimethylarginine (ADMA): an endogenous inhibitor of nitric oxide synthase and a novel cardiovascular risk molecule. Med Sci Monit 2009, 15:RA91-RA101.
26. Smirnova I.V., Sawamura T., Goligorsky M.S. Upregulation of lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) in endothelial cells by nitric oxide deficiency. Am J Physiol Ren Physiol 2004, 287:F25-F32.
27. van Leeuwen M., Damoiseaux J., Duijvestijn A., Tervaert J.W. The therapeutic potential of targeting B cells and anti-oxLDL antibodies in atherosclerosis. Autoimmun Rev 2009, 9:53-57.
28. Veresh Z., Racz A., Lotz G., Koller A. ADMA impairs nitric oxide-mediated arteriolar function due to increased superoxide production by angiotensin II-NAD(P)H oxidase pathway. Hypertension 2008, 52:960-966.
29. Camici P.G., Crea F. Coronary microvascular dysfunction. N Engl J Med 2007, 356:830-840.
30. Turiel M., Sitia S., Atzeni F., Tomasoni L., Gianturco L., Giuffrda M., et al. The heart in rheumatoid arthritis. Autoimmun Rev 2010, 9:414-418.
31. Picano E., Pálinkás A., Amyot R. Diagnosis of myocardial ischemia in hypertensive patients. J Hypertens 2001, 19:1177-1183.
32. Lerman A., Zeiher Endothelial function: cardiac events. Circulation 2005, 111:363-368.
33. Sitia S., Atzeni F., Sarzi-Puttini P., Di Bello V., Tomasoni L., Delfino L., et al. Cardiovascular involvement in sistemi autoimmune diseases. Autoimmun Rev 2009, 8:281-286.
34. Cortigiani L., Rigo F., Gherardi S., Sicari R., Galderisi M., Bovenzi F., et al. Additional prognostic value of coronary flow reserve in diabetic and nondiabetic patients with negative dipyridamole stress echocardiography by wall motion criteria. J Am Coll Cardiol 2007, 50:1354-1361.
35. Cortigiani L., Rigo F., Sicari R., Gherardi S., Bovenzi F., Picano E. Prognostic correlates of combined coronary flow reserve assessment on left anterior descending and right coronary artery in patients with negative stress echocardiography by wall motion criteria. Heart 2009, 95:1423-1428.
36. Rigo F., Sicari R., Gherardi S., Djordjevic-Dikic A., Cortigiani L., Picano E. The additive prognostic value of wall motion abnormalities and coronary flow reserve during dipyridamole stress echo. Eur Heart J 2008, 29:79-88.
37. Rigo F., Sicari R., Gherardi S., Djordjevic-Dikic A., Cortigiani L., Picano E. Prognostic value of coronary flow reserve in medically treated patients with left anterior descending coronary disease with stenosis 51%-75% in diameter. Am J Cardiol 2007, 100:1527-1531.